IncellDx Releases CE-IVD Quantitative Single Cell PD-L1 OncoTect iO® Assay

/in , , , /by

MENLO PARK, Calif.–IncellDx, Inc. announces the release of their CE marked OncoTect iO® Lung Kit today, March 30, 2017, entering the immunotherapeutic diagnostic market in Europe and countries that accept the CE- mark and declaration of conformity to the European In Vitro Diagnostic Directive 98/79 EC for registration of in vitro diagnostic devices. The OncoTect […]

Read more →

New Research Innovations in Liquid Biopsy, Bioinformatics and Liquid Handling Advance Future of Precision Medicine

/in , , , , , /by

Broad spectrum of technological advances for cancer research on display at AACR 2017 WASHINGTON, D.C.–AACR 2017 – Thermo Fisher Scientific, the world leader in serving science, will highlight its latest innovative solutions for research designed to help customers advance the future of precision medicine. The new products and a wide spectrum of scientific posters will […]

Read more →

CARL R. WOESE INSTITUTE FOR GENOMIC BIOLOGY, UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN A new agreement between the Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois at Urbana-Champaign and ZEISS has named the Core Facilities at IGB as an official ZEISS labs@location Partner. The model facility will allow researchers from around the U.S. to test-drive new instruments in the IGB’s Core Facilities Microscopy Suite. This partnership represents the first North American location of the ZEISS labs@location partner program, already in use across Europe. “With this special partnership with IGB Core Facilities, we transfer a successful labs@location program from Europe to the U.S.,” said Jim Sharp, President Carl Zeiss Microscopy LLC. “labs@location is a community of our ZEISS customers and partners providing in depth knowledge and dedicated services. We are very excited that the IGB becomes our first American ZEISS labs@location.” The agreement will allow IGB and Illinois researchers access to select cutting edge technologies immediately following–or in some cases before–their broad release. New instruments, on loan from ZEISS, will cycle through the Core and be available to all users during that time. In addition, the agreement provides for training and classes taught by ZEISS personnel at the IGB that will better position Core staff and researchers to best utilize new equipment. ZEISS instrument specialists will provide instruction and instrument demos to Illinois and visiting scientists, as well as assist in training the IGB Core staff to provide similar instruction themselves. “ZEISS training is really valuable,” said Core Facilities Director Glenn Fried, “but until now, you’ve had to send your people to the ZEISS Microscopy Customer Center in New York twice a year to see that benefit. Now all of my staff, as well as graduate students, postdocs, and faculty, can come to those classes at the IGB.” Fried anticipates that one of the first new instruments under the agreement will be a ZEISS Celldiscoverer 7, a new automated microscopy platform for high throughput live cell imaging. Though the IGB has equipment for that purpose, Fried says that the ZEISS Celldiscoverer 7 offers improved clarity and visibility, allowing for sharper and more accurate images. “This is a really exciting thing for the Core, and for everyone who uses our instruments,” said Fried. “Researchers will have access to the newest technology–like ZEISS Celldiscoverer–long before they would if we had to write a grant or even just went out and bought it.” In all, the ZEISS partnership promises to establish itself as a regional center of excellence in biological imaging by attracting researchers from around the country to demo new instruments and attend trainings. “We are thrilled to partner with ZEISS in this way, because it will enhance the research capabilities of scientists studying many different types of questions, thus enabling the IGB to provide an important new benefit to the campus. Being selected by ZEISS to be the first labs@location in North America is a great honor, and a recognition of the excellence of our Core Facilities and especially the entire Core Facilities staff,” said IGB Director Gene Robinson.

/in , , /by

MOUNTAIN VIEW, Calif. — Cellecta, Inc. today announced the launch of the Driver-Map™ Human Genome-Wide Gene Expression Profiling kit, a targeted RNA expression profiling assay designed to easily provide a molecular snapshot of all known 19,000 human protein-coding genes from complex samples starting from as little as 10 pg of total RNA. The multiplex RT-PCR-based, followed […]

Read more →

Arrayjet inks a ‘major’ boost from $250,000 contract win with New York Bioscience Cluster

/in , , , /by

Arrayjet, the Midlothian-based microarray instrumentation company, has secured a contract with/within The New York Bioscience Cluster, one of America’s premier medical education and biomedical research facilities. The Bronx-based bioscience cluster continues to ‘future proof’ its microarray printing development, improve its research services and grow its cliental base.  It continues a quest to target important problems […]

Read more →

LabNetwork Integrates with Reaxys to Offer Seamless Experience from Chemistry Research to Purchase

/in , /by

SHANGHAI; BOSTON, Mass. – LabNetwork, WuXi AppTec’s global chemistry ecommerce platform company, today announced a new collaboration with Elsevier, a world-leading provider of scientific, technical and medical information products and services. LabNetwork’s nearly four million commercially available discovery and research compounds will now be directly available to users of Reaxys, Elsevier’s premier chemistry database. The […]

Read more →

Pressure BioSciences, Inc. Significantly Expands Marketing and Sales Capabilities

/in , , /by

SOUTH EASTON, MA — Pressure BioSciences, Inc. ( OTCQB : PBIO ) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced that it has significantly bolstered its marketing and sales capabilities by contracting with well-known […]

Read more →

Hamilton Robotics and Zymo Research Corporation Collaborate to Enable High Throughput Epigenetics Research

/in , , , , /by

Automated Workflows Open New Avenues in the Rapidly-Expanding Epigenetic Frontier Reno, Nev. – Hamilton Robotics and Zymo Research Corporation announced an ongoing collaboration that unites Zymo Research’s epigenetics innovations with Hamilton’s high-throughput workflow expertise. A number of Zymo Research assay chemistries are now optimized for use on Hamilton’s automated liquid handling workstations, including a time-saving and […]

Read more →

Addgene Announces Alnylam and New England Biolabs Sponsorships

/in , , /by

AMBRIDGE, Mass. — Addgene announces Alnylam and New England Biolabs® (NEB®) as founding sponsors of Addgene’s new Viral Service launched in late 2016. Addgene’s nonprofit mission is to accelerate research and discovery by improving access to useful research materials and information. The organization is now providing scientists with ready-to-use viral samples derived from the Addgene plasmid […]

Read more →

SeraCare Life Sciences announces launch of industry’s first multiplexed Inherited Cancer reference material

/in , , , /by

Expert-designed material for simplified validation of NGS-based panels MILFORD, Mass. — SeraCare Life Sciences, a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories is announcing the launch of the industry’s first multiplexed Inherited Cancer reference material for inherited disease testing by next-generation sequencing (NGS).  The Seraseq™ Inherited Cancer DNA Mix reference materials were developed with […]

Read more →

Swift Biosciences Launches New Assay for Faster, More Efficient Routine Screening of the CFTR Gene

/in , , , /by

Accel-Amplicon™ CFTR Panel presented at the 2017 American College of Medical Genetics Annual Meeting (ANN ARBOR, Mich.) Swift Biosciences today announced the commercial release of its Accel-Amplicon CFTR Panel. This panel will offer research laboratories a more comprehensive, next-generation sequencing (NGS)-based approach to interrogate the coding region and select introns within the Cystic Fibrosis Transmembrane […]

Read more →